International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
24(1), P. 350 - 350
Published: Dec. 26, 2022
Major
depressive
disorder
(MDD)
is
widely
accepted
as
having
a
heterogenous
pathophysiology
involving
complex
mixture
of
systemic
and
CNS
processes.
A
developmental
etiology
coupled
to
genetic
epigenetic
risk
factors
well
lifestyle
social
process
influences
add
further
the
complexity.
Consequently,
antidepressant
treatment
generally
regarded
open
improvement,
undoubtedly
consequence
inappropriately
targeted
pathophysiological
This
article
reviews
diverse
array
processes
linked
MDD,
integrates
these
within
perspective
that
emphasizes
alterations
in
mitochondrial
function,
both
centrally
systemically.
It
proposed
long-standing
association
MDD
with
suppressed
serotonin
availability
reflective
role
precursor
for
melatonergic
pathway.
Astrocytes,
astrocyte
pathway,
are
highlighted
crucial
hubs
integration
wide
biological
underpinnings
including
gut
dysbiosis
permeability,
stressors,
which
can
act
suppress
capacity
mitochondria
upregulate
consequences
oxidant-induced
changes
patterned
microRNAs
subsequent
gene
responses.
placed
development
context,
how
processes,
such
discrimination,
physiologically
regulate
susceptibility
MDD.
Future
research
directions
implications
derived
from
this.
Biomedicines,
Journal Year:
2023,
Volume and Issue:
11(2), P. 294 - 294
Published: Jan. 20, 2023
Gut
microbes
and
their
metabolites
are
actively
involved
in
the
development
regulation
of
host
immunity,
which
can
influence
disease
susceptibility.
Herein,
we
review
most
recent
research
advancements
gut
microbiota–immune
axis.
We
discuss
detail
how
microbiota
is
a
tipping
point
for
neonatal
immune
as
indicated
by
newly
uncovered
phenomenon,
such
maternal
imprinting,
utero
intestinal
metabolome,
weaning
reaction.
describe
shapes
both
innate
adaptive
immunity
with
emphasis
on
short-chain
fatty
acids
secondary
bile
acids.
also
comprehensively
delineate
disruption
axis
results
immune-mediated
diseases,
gastrointestinal
infections,
inflammatory
bowel
cardiometabolic
disorders
(e.g.,
cardiovascular
diabetes,
hypertension),
autoimmunity
rheumatoid
arthritis),
hypersensitivity
asthma
allergies),
psychological
anxiety),
cancer
colorectal
hepatic).
further
encompass
role
fecal
transplantation,
probiotics,
prebiotics,
dietary
polyphenols
reshaping
therapeutic
potential.
Continuing,
examine
modulates
therapies,
including
checkpoint
inhibitors,
JAK
anti-TNF
therapies.
lastly
mention
current
challenges
metagenomics,
germ-free
models,
recapitulation
to
achieve
fundamental
understanding
regulates
immunity.
Altogether,
this
proposes
improving
immunotherapy
efficacy
from
perspective
microbiome-targeted
interventions.
Neurobiology of Disease,
Journal Year:
2023,
Volume and Issue:
179, P. 106033 - 106033
Published: Feb. 8, 2023
Research
in
the
last
decade
has
unveiled
a
crucial
role
for
trillions
of
microorganisms
that
reside
gut
influencing
host
neurodevelopment
across
lifespan
via
microbiota-gut-brain
axis.
Studies
have
linked
alterations
composition,
complexity,
and
diversity
microbiota
to
changes
behaviour
including
abnormal
social
interactions,
cognitive
deficits,
anxiety-
depressive-like
phenotypes.
Moreover,
been
with
neurodevelopmental,
neuropsychiatric,
neurodegenerative
disorders.
Interestingly,
there
appears
be
specific
brain
regions
governing
neurocircuitry
driving
higher
function
are
susceptible
influence
from
manipulations
microbiome.
This
review
will
aim
elucidate
region-specific
effects
mediated
by
microbiota,
focus
on
translational
animal
models
some
existing
human
neuroimaging
data.
Compelling
preclinical
evidence
suggests
disruption
normal
signalling
can
detrimental
prefrontal
cortex,
amygdala,
hippocampus,
hypothalamus,
striatum.
Furthermore,
studies
mediating
functional
connectivity
structure
traced
back
neurocognition
behavioural
output.
Understanding
these
microbiota-mediated
aid
identifying
unique
therapeutic
targets
treating
neurological
disorders
associated
regions.
Nutrients,
Journal Year:
2024,
Volume and Issue:
16(2), P. 272 - 272
Published: Jan. 17, 2024
(1)
Background:
The
first
1000
days
of
life
constitute
a
critical
window
opportunity
for
microbiota
development.
Nutrients
play
crucial
role
in
enriching
and
diversifying
the
microbiota,
derived
not
only
from
solid
food
but
also
maternal
dietary
patterns
during
gestation.
(2)
Methods:
We
conducted
comprehensive
literature
review
using
PubMed
database,
covering
eleven
years
(2013–2023).
included
English-language
reviews,
original
research
papers,
meta-analyses,
while
excluding
case
reports
letters.
(3)
Results:
Consensus
emphasizes
that
our
interaction
with
multitude
microorganisms
begins
intrauterine
environment
continues
throughout
lives.
existing
data
suggest
early
nutritional
education
programs,
initiated
pregnancy
guiding
infant
diets
development,
may
influence
shaping
gut
promoting
long-term
health.
(4)
Conclusions:
Further
is
necessary
coming
to
assess
potential
interventions
models
aimed
at
modulating
pediatric
especially
vulnerable
populations
such
as
premature
newborns.
Children,
Journal Year:
2024,
Volume and Issue:
11(5), P. 552 - 552
Published: May 5, 2024
Over
the
past
decade,
microbiome
research
has
significantly
expanded
in
both
scope
and
volume,
leading
to
development
of
new
models
treatments
targeting
gut–brain
axis
mitigate
effects
various
disorders.
Related
suggests
that
interventions
during
critical
period
from
birth
three
years
old
may
yield
greatest
benefits.
Investigating
substantial
link
between
gut
brain
this
crucial
developmental
phase
raises
fundamental
issues
about
role
microorganisms
human
health
development.
This
underscores
importance
focusing
on
prevention
rather
than
treatment
neurodevelopmental
neuropsychiatric
The
present
review
examines
microbiota
age
3,
with
a
particular
focus
its
potential
relationship
neurodevelopment.
emphasizes
immunological
mechanisms
underlying
relationship.
Additionally,
study
investigates
impact
cognitive
neurobehavioral
such
as
anxiety
autism.
Importantly,
it
highlights
need
integrate
mechanistic
studies
animal
epidemiological
across
diverse
cultures
better
understand
healthy
early
life
implications
dysbiosis.
Furthermore,
summarizes
factors
contributing
transmission
microbiome-targeted
therapies
their
Recent
environmental
toxins
known
neurodevelopment
are
also
reviewed,
exploring
whether
or
modulate
these
effects.
Brain Behavior & Immunity - Health,
Journal Year:
2024,
Volume and Issue:
36, P. 100730 - 100730
Published: Jan. 26, 2024
Psychosocial
stress
and
mood-related
disorders,
such
as
depression,
are
prevalent
vulnerability
to
these
conditions
is
heightened
during
pregnancy.
induces
consequences
via
several
mechanisms
including
the
gut
microbiota-brain
axis
associated
signaling
pathways.
Previous
preclinical
work
indicates
that
prenatal
alters
maternal
microbial
composition
impairs
offspring
development.
Importantly,
although
fecal
vaginal
microenvironments
undergo
alterations
across
pregnancy,
we
lack
consensus
regarding
which
shifts
adaptive
or
maladaptive
in
presence
of
depression.
Clinical
studies
interrogating
relationships
have
identified
unique
taxa
but
been
limited
study
design.
Psychoneuroendocrinology,
Journal Year:
2025,
Volume and Issue:
172, P. 107273 - 107273
Published: Jan. 2, 2025
Maternal
stress
can
have
short
and
long
term
adverse
(mental)
health
effects
for
the
mother
her
child.
Previous
evidence
suggests
that
gut
microbiota
may
be
a
potential
mediator
moderator
of
via
various
pathways.
This
study
explored
maternal
trajectory
during
pregnancy
as
well
association
between
pre-
postnatal
features
infant
after
pregnancy.
In
line
with
previous
research,
we
hypothesized
would
positively
related
to
volatility
infants
highly
stressed
mothers
show
relative
increase
in
Proteobacteria
decrease
Bifidobacterium.
We
collected
stool
samples
at
18
32
weeks
8
months
postpartum.
Infant
stools
were
obtained
2,
6
12
All
analyzed
using
shotgun
metagenome
sequencing.
also
several
measures
(self-reported
depression,
anxiety,
stress,
hair
cortisol
cortisone),
most
same
time
points
samples.
Our
data
indicated
does
not
undergo
drastic
changes
from
second
third
trimester
but
postpartum
differs
significantly
prenatal
microbiota.
Furthermore,
identified
associations
different
including
positive
negative
alpha
diversity,
beta
diversity
individual
microbial
phyla
species
abundances.
Also,
composite
score,
perceived
score
log-ratio
cortisone
all
associated
volatility.
provides
is
both
Collectively,
this
studies
indicate
uniformly
associate
features.
Instead,
are
point
specific.
Regarding
volatility,
consistently
found
warrants
future
research
investigating
link
more
depth.
PLoS ONE,
Journal Year:
2025,
Volume and Issue:
20(2), P. e0318237 - e0318237
Published: Feb. 28, 2025
Background
Perinatal
maternal
stress,
which
includes
both
psychological
and
physiological
stress
experienced
by
healthy
women
during
pregnancy
the
postpartum
period,
is
becoming
increasingly
prevalent.
Infant
early
exposure
to
adverse
environments
such
as
perinatal
has
been
shown
increase
long-term
risk
metabolic,
immunologic
neurobehavioral
disorders.
Evidence
suggests
that
human
microbiome
facilitates
transmission
of
factors
infants
via
vaginal,
gut,
milk
microbiomes.
The
colonization
aberrant
microorganisms
in
mother’s
microbiome,
influenced
microbiome-brain-gut
axis,
may
be
transferred
a
critical
developmental
period.
This
transfer
predispose
more
inflammatory-prone
associated
with
dysregulated
metabolic
process
leading
health
outcomes.
Given
prevalence
potential
impact
on
infant
health,
no
systematic
mapping
or
review
data
date,
aim
this
scoping
gather
evidence
relationship
between
milk,
maternal,
gut
Methods
an
exploratory
review,
guided
Joanna
Briggs
Institute’s
methodology
along
use
Prisma
Scr
reporting
guideline.
A
comprehensive
search
was
conducted
using
following
databases,
CINAHL
Complete;
MEDLINE;
PsycINFO,
Web
Science
Scopus
protocol
registered
Open
Framework
DOI
10.17605/OSF.IO/5SRMV.
Results
After
screening
1145
papers
there
were
7
paper
met
inclusion
criteria.
Statistically
significant
associations
found
five
studies
identify
higher
abundance
potentially
pathogenic
bacteria
Erwinia,
Serratia,
T
mayombie,
Bacteroides
lower
levels
linked
beneficial
Lactococcus,
Lactobacillus,
Akkermansia.
However,
one
study
presents
conflicting
results
where
it
reported
bacteria.
Conclusion
does
have
alteration
diversity
influential
however,
can
affect
colonisation
different
ways.
These
bacterial
changes
capacity
influence
long
term
disease.
analyses
collection
tools
methods,
offers
reasons
for
these
findings
well
suggestions
future
research.
Brain Behavior and Immunity,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 1, 2025
Accumulating
evidence
suggests
the
microbiota
is
a
key
factor
in
Disorders
of
Gut-Brain
Interaction
(DGBI),
by
affecting
host
immune
and
neural
systems.
However,
underlying
mechanisms
remain
elusive
due
to
their
complexity
clinical
heterogeneity
patients
with
DGBIs.
We
aimed
identify
neuroimmune
pathways
that
are
critical
microbiota-gut-brain
communication
during
de
novo
gut
colonization.
employed
combination
gnotobiotic
state-of-the-art
microbial
tools,
behavioral
analysis,
pharmacological
approaches.
Germ-free
wild
type,
TLR
signaling-deficient
MyD88-/-
Ticam1-/-
lymphocyte-deficient
SCID
mice
were
studied
before
after
colonization
specific
pathogen-free
microbiota,
Altered
Schaedler
Flora,
E.
coli
or
S.
typhimurium
(permanent
transient
colonizers).
agonists
antagonists,
CCR7
antagonist
immunomodulators
used
study
pathways.
assessed
brain
c-Fos,
brain-derived
neurotrophic
factor,
dendritic
glial
cells
immunofluorescence,
expression
genes
NanoString
performed
proteomics.
Bacterial
monocolonization,
conventionalization
administration
products
germ-free
altered
mouse
behavior
similarly,
acting
through
Toll-like
receptor
nucleotide-binding
oligomerization
domain
signaling.
The
process
required
CD11b+CD11c+CD103+
cell
activation
migration
into
brain.
change
did
not
require
continued
presence
bacteria
was
associated
multiple
neuro-immune
networks
Changes
plasticity
occur
rapidly
upon
initial
involve
innate
signaling
brain,
mediated
migration.
results
new
target
therapeutic
potential
for
DGBIs
developing
context
increased
blood-brain
barrier
permeability.